Suven Life Sciences was promoted by Mrs. and Mr. Venkat Jasti as a Private Limited Company & it was converted into a Public Limited Company in January 1995.

This pharma stock enjoys a very high margin, which operates out of the new chemical entity-based, contract research-manufacturing space. They are also US FDA certified for it’s suryapet facility at Nalagonda district in Telangana state.

Today(22-May-2015) Suven Life Sciences Ltd secured two product patents, one each from Mexico and Singapore, for the treatment of disorders associated with neurodegenerative diseases.
With these new patents, Suven has a total of 18 granted patents from Mexico and 20 granted patents from Singapore.

This stock can be considered for long term investment to reap more than 100% profit in next 2 to 3 years from CMP – 300 to 320. If you are a short term investor then don’t invest in this stock.